TOBY ATLASNCT07933042
A Study of Urine Volatile Organic Compounds for Disease Detection
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria changed
- Study description expanded, about 35 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Clinical performance of each locked assay
Timeframe: At specimen collection and reference-standard assessment, including medical-record review at approximately 12 months where available.
Paired comparison with available standard-of-care tests
Timeframe: At specimen collection and reference-standard assessment, including medical-record review at approximately 12 months where available.
Secondary (2)
Assay performance by subgroup and signal origin
Protocol-conforming specimens with final reference-standard classification
Arms and interventions
Target disease cases
Participants with a target disease established by the applicable reference standard, including participants assessed after treatment where specified.
Controls
Participants without the target disease for a given analysis, including healthy participants and participants with other diseases, benign conditions, or negative diagnostic work-ups.